DrugPatentWatch Database Preview

Drugs in Development Information for L-Alanine

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug L-Alanine?

L-Alanine is an investigational drug.

There have been 8 clinical trials for L-Alanine. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1^st 2013.

The most common disease conditions in clinical trials are Myocardial Ischemia, Coronary Disease, and Coronary Artery Disease. The leading clinical trial sponsors are University of Southern California, Children's Hospital Medical Center, Cincinnati, and Oregon Research Institute.

There are two hundred and twenty-three US patents protecting this investigational drug and two international patents.

Summary for L-Alanine

US Patents	223
International Patents	2,265
US Patent Applications	257
WIPO Patent Applications	1
Japanese Patent Applications	0
Clinical Trial Progress	Phase 3 (2013-11-01)
Vendors	88

Recent Clinical Trials for L-Alanine

Title	Sponsor	Phase
Antiviral Therapy and Baricitinib for the Treatment of Patients With Moderate or Severe COVID-19	National Cancer Institute (NCI)	Phase 2
Antiviral Therapy and Baricitinib for the Treatment of Patients With Moderate or Severe COVID-19	University of Southern California	Phase 2
Impact of Perioperative Treatment With Intravenous Glutamine on Myocardial Protection in Cardiac Surgery Patients With Aortic Stenosis	Yonsei University	N/A

See all L-Alanine clinical trials

Clinical Trial Summary for L-Alanine

Top disease conditions for L-Alanine

Top clinical trial sponsors for L-Alanine

See all L-Alanine clinical trials

US Patents for L-Alanine

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
L-Alanine		Synthetic polymeric drugs	Ceskoslovenska Akademie Ved (Praha, CS) Carlton Medical Products Limited (London, GB2)
L-Alanine		Substituted amino acid compounds	Adir et Compagnie (Courbevoie, FR)
L-Alanine		Solid phase peptide synthesis using a polyacrylic support in aqueous solution	Societe d'Expansion Scientifque Expansia (FR)
L-Alanine		Cyclic anticoagulant peptides	Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH)
L-Alanine		Azoxy compounds	Kowa Company Ltd. (Aichi, JP)
L-Alanine		Use of glutamine to reduce rate of pathogenic microorganism infection	Brigham and Women's Hospital (Boston, MA)
L-Alanine		Amino nitrile intermediate for the preparation of alanine diacetic acid	The Dow Chemical Company (Midland, MI)

International Patents for L-Alanine

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
L-Alanine	Austria	60991	2005-01-04
L-Alanine	Australia	5183386	2005-01-04
L-Alanine	Australia	589587	2005-01-04
L-Alanine	Canada	1305053	2005-01-04
L-Alanine	Germany	3581921	2005-01-04
L-Alanine	Denmark	164485	2005-01-04
L-Alanine	Denmark	3386	2005-01-04